The tumor responded to adjuvant chemotherapy with ifosfamide, vincristine, and actinomycin D. FusionSeq revealed aTFG-MET fusion, validated by reverse transcription-polymerase chain reaction (RT-PCR) and FISH. This evidence concerns the gene MET and neoplasm.